Clinical Trials Browser

Phase 3 × binimetinib × Gynecologic × Clear all

NCT01849874 2023-10-30

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Phase 3 Terminated

341 enrolled 15 charts

Low-grade Serous Ovarian Cancer